Palombo C, Marabotti C, Genovesi-Ebert A, Giaconi S, Michelassi C, Fommei E, Ghione S
Institute of Medical Pathology, Medical School, University of Pisa, Italy.
J Cardiovasc Pharmacol. 1988;12 Suppl 6:S135-42. doi: 10.1097/00005344-198812006-00034.
Nitrendipine is a second-generation dihydropyridine calcium antagonist selective for hypertension. The aim of this study was to assess whether, in addition to reduce resting blood pressure, nitrendipine also affects the cardiovascular reactivity to physical and psychologic stress. Ten essential hypertensive patients, out of treatment for at least 2 weeks, underwent a symptom-limited dynamic maximal exercise and a mental arithmetic stress test (MAT) after placebo (1 week) and 1 and 5 weeks of active treatment with nitrendipine (20 mg q.i.d.). To evaluate the cardiovascular response to exercise and its changes during treatment, the slope of the regression line (if statistically significant) of the blood pressure, heart rate, and rate-pressure product (RPP) values against workload were considered, together with exercise capacity, blood pressure, and pressure-rate product at the peak of maximal exercise. During mental stress, indexes of stroke volume (SVI), cardiac output (COI), and peripheral resistance (TPRI) were obtained by Doppler transcutaneous aortovelography (TAV). Resting systolic and diastolic BP were significantly reduced during treatment. The average length of exercise was 7.3, 7.64, and 8.0 min after, respectively, placebo, 1, and 5 weeks of treatment. Peak systolic and diastolic BP, peak RPP, and RPP slope were consistently decreased after treatment, significantly for peak DBP and RPP. During mental arithmetics, a significant increase of BP and HR and a decrease of SVI were observed on placebo; both BP and SVI responses disappeared after 5 weeks on nitrendipine, whereas the HR increase was unchanged. Peak values of COI and TPRI during MAT were significantly increased and decreased, respectively, after nitrendipine, whereas basal values showed similar changes, but not statistically significant.(ABSTRACT TRUNCATED AT 250 WORDS)
尼群地平是一种用于治疗高血压的第二代二氢吡啶类钙拮抗剂。本研究的目的是评估尼群地平除了降低静息血压外,是否还会影响心血管对身体和心理应激的反应性。10例原发性高血压患者,至少停药2周,在服用安慰剂(1周)以及服用尼群地平(20mg,每日4次)进行1周和5周的积极治疗后,接受了症状限制的动态最大运动和心算应激试验(MAT)。为了评估运动时的心血管反应及其在治疗期间的变化,考虑了血压、心率和速率-压力乘积(RPP)值相对于工作量的回归线斜率(如果具有统计学意义),以及最大运动峰值时的运动能力、血压和压力-速率乘积。在精神应激期间,通过多普勒经皮主动脉血流图(TAV)获得每搏输出量(SVI)、心输出量(COI)和外周阻力(TPRI)指标。治疗期间静息收缩压和舒张压显著降低。安慰剂、治疗1周和5周后,运动的平均时长分别为7.3、7.64和8.0分钟。治疗后,收缩压和舒张压峰值、RPP峰值和RPP斜率持续下降,舒张压峰值和RPP显著下降。在心算期间,服用安慰剂时观察到血压和心率显著升高,SVI降低;服用尼群地平5周后,血压和SVI反应均消失,而心率升高未改变。服用尼群地平后,MAT期间COI和TPRI的峰值分别显著升高和降低,而基础值显示出类似变化,但无统计学意义。(摘要截断于250字)